St. John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, Guy's Hospital, London, SE1 9RT, UK.
MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Box 197, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
Sci Rep. 2021 Feb 17;11(1):3962. doi: 10.1038/s41598-021-83352-4.
T-cell non-Hodgkin's lymphomas develop following transformation of tissue resident T-cells. We performed a meta-analysis of whole exome sequencing data from 403 patients with eight subtypes of T-cell non-Hodgkin's lymphoma to identify mutational signatures and associated recurrent gene mutations. Signature 1, indicative of age-related deamination, was prevalent across all T-cell lymphomas, reflecting the derivation of these malignancies from memory T-cells. Adult T-cell leukemia-lymphoma was specifically associated with signature 17, which was found to correlate with the IRF4 K59R mutation that is exclusive to Adult T-cell leukemia-lymphoma. Signature 7, implicating UV exposure was uniquely identified in cutaneous T-cell lymphoma (CTCL), contributing 52% of the mutational burden in mycosis fungoides and 23% in Sezary syndrome. Importantly this UV signature was observed in CD4 + T-cells isolated from the blood of Sezary syndrome patients suggesting extensive re-circulation of these T-cells through skin and blood. Analysis of non-Hodgkin's T-cell lymphoma cases submitted to the national 100,000 WGS project confirmed that signature 7 was only identified in CTCL strongly implicating UV radiation in the pathogenesis of cutaneous T-cell lymphoma.
T 细胞非霍奇金淋巴瘤是组织固有 T 细胞转化后发展而来的。我们对 403 例八种 T 细胞非霍奇金淋巴瘤患者的全外显子组测序数据进行了荟萃分析,以鉴定突变特征和相关的复发性基因突变。标志 1 表明与年龄相关的脱氨作用,存在于所有 T 细胞淋巴瘤中,反映了这些恶性肿瘤来源于记忆 T 细胞。成人 T 细胞白血病/淋巴瘤与标志 17 特异性相关,标志 17 被发现与仅存在于成人 T 细胞白血病/淋巴瘤中的 IRF4 K59R 突变相关。标志 7 表明与紫外线暴露有关,在皮肤 T 细胞淋巴瘤(CTCL)中是独特的,在蕈样真菌病中占突变负担的 52%,在 Sezary 综合征中占 23%。重要的是,在 Sezary 综合征患者血液中分离的 CD4+T 细胞中观察到这种 UV 特征,这表明这些 T 细胞通过皮肤和血液进行了广泛的再循环。对提交给国家 10 万基因组测序项目的非霍奇金 T 细胞淋巴瘤病例进行分析证实,标志 7 仅在 CTCL 中被识别,强烈提示紫外线辐射在皮肤 T 细胞淋巴瘤的发病机制中起作用。